Literature DB >> 3905614

Importance of a lipopolysaccharide-containing extracellular toxic complex in infections produced by Klebsiella pneumoniae.

D C Straus, D L Atkisson, C W Garner.   

Abstract

A Klebsiella pneumoniae serotype 2 strain was examined for its ability to produce extracellular toxic material. The organism was grown to the stationary phase in a defined medium, and the toxic material was isolated by ultrafiltration-ion-exchange chromatography on DEAE-Sephacel and gel filtration chromatography on Sepharose 4B or 2B. It was found to be comprised of 63% capsular polysaccharide, 30% lipopolysaccharide, and 7% protein and possessed a 50% lethal dose (when injected intraperitoneally into mice) of 393 +/- 45 micrograms. The toxicity appeared to be associated with the endotoxin portion of the compound, because boiling for 15 min and exposure to proteolytic enzymes had no effect on the toxicity. However, saponification destroyed the toxicity of the compound. Studies employing radial immunodiffusion examining the sera of mice infected with this organism demonstrated in vivo production of the complex at levels sufficiently high to produce death. When sublethal amounts of this complex were placed in the lungs of specific-pathogen-free mice, the lung pathology observed after 24, 48, and 72 h was similar to the damage caused by an active K. pneumoniae lobar pneumonia. These data indicate that this extracellular toxic compound produced by K. pneumoniae may be responsible for the lethality and lung tissue destruction normally associated with an active lobar pneumonia caused by this organism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905614      PMCID: PMC261149          DOI: 10.1128/iai.50.3.787-795.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  STUDIES ON THE GRAM-NEGATIVE CELL WALL. I. EVIDENCE FOR THE ROLE OF 2-KETO- 3-DEOXYOCTONATE IN THE LIPOPOLYSACCHARIDE OF SALMONELLA TYPHIMURIUM.

Authors:  M J OSBORN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-09       Impact factor: 11.205

2.  The effect of the dose of bacterial polysaccharide antigen on antibody production in mice.

Authors:  H BAER; J K BRINGAZE; M McNAMEE
Journal:  J Bacteriol       Date:  1954-01       Impact factor: 3.490

3.  Effect of capsular polysaccharide of Klebsiella pneumoniae on the differentiation and functional capacity of macrophages cultured in vitro.

Authors:  T Yokochi; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1977-10-20       Impact factor: 1.955

4.  New method for quantitative determination of uronic acids.

Authors:  N Blumenkrantz; G Asboe-Hansen
Journal:  Anal Biochem       Date:  1973-08       Impact factor: 3.365

5.  Friedlander's pneumonia. A report of 11 cases and appraisal of antibiotic therapy.

Authors:  N R Hoffman; F S Preston
Journal:  Dis Chest       Date:  1968-04

6.  Controlled trials of a polyvalent pseudomonas vaccine in burns.

Authors:  R J Jones; E A Roe; J L Gupta
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

7.  A hospital outbreak of Klebsiella pneumonia from inhalation therapy with contaminated aerosol solutions.

Authors:  J J Mertz; L Scharer; J H McClement
Journal:  Am Rev Respir Dis       Date:  1967-03

8.  Isolation and analysis of the lipid A backbone. Lipid A structure of lipopolysaccharides from various bacterial groups.

Authors:  S Hase; E T Rietschel
Journal:  Eur J Biochem       Date:  1976-03-16

9.  Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence.

Authors:  P Domenico; D L Diedrich; D C Straus
Journal:  Can J Microbiol       Date:  1985-05       Impact factor: 2.419

10.  Immunological properties of purified Klebsiella pneumoniae heat-stable enterotoxin.

Authors:  F A Klipstein; R F Engert; R A Houghten
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

View more
  17 in total

Review 1.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

Review 2.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

3.  O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections.

Authors:  M Trautmann; M Ruhnke; T Rukavina; T K Held; A S Cross; R Marre; C Whitfield
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

4.  Structure of the core oligosaccharide in the serotype O8 lipopolysaccharide from Klebsiella pneumoniae.

Authors:  W B Severn; R F Kelly; J C Richards; C Whitfield
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

5.  Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia.

Authors:  T K Held; M Trautmann; M E Mielke; H Neudeck; S J Cryz; A S Cross
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae.

Authors:  D C Straus
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

7.  Immunization against fatal experimental Klebsiella pneumoniae pneumonia.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

8.  A novel outer membrane protein, Wzi, is involved in surface assembly of the Escherichia coli K30 group 1 capsule.

Authors:  Andrea Rahn; Kostantinos Beis; James H Naismith; Chris Whitfield
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

9.  Quantitation and biological properties of released and cell-bound lipooligosaccharides from nontypeable Haemophilus influenzae.

Authors:  X X Gu; C M Tsai; M A Apicella; D J Lim
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Klebsiella pneumoniae triggers a cytotoxic effect on airway epithelial cells.

Authors:  Victoria Cano; David Moranta; Enrique Llobet-Brossa; José Antonio Bengoechea; Junkal Garmendia
Journal:  BMC Microbiol       Date:  2009-08-03       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.